Form 4: HeartBeam CEO's Equity Holdings Update

HeartBeam CEO Branislav Vajdic reports changes in his beneficial ownership of common stock and derivative securities, including new option grants.

Summary

• Branislav Vajdic, Chief Executive Officer of HeartBeam, Inc. (BEAT), has filed a Form 4 statement regarding his beneficial ownership.
• He directly owns 878,664 shares of HeartBeam Common Stock.
• He also beneficially owns 1,428,424 derivative securities, which are options to buy Common Stock.
• These options have an exercise price of $1.65 per share and an expiration date of July 1, 2035.
• The options were granted on September 30, 2025, as part of the Company's 2022 Equity Incentive Plan.
• The vesting schedule for these options is as follows: one half will vest on October 1, 2025 (three months from the July 1, 2025 vesting commencement date), and the remaining half will vest on January 1, 2026 (six months from the vesting commencement date).

Sentiment

Score: 7

Explanation: The grant of stock options to the CEO is generally viewed positively as it aligns management incentives with shareholder interests, indicating a commitment to long-term value creation. This is a routine compensation event, not directly indicative of operational performance.

Positives

• The grant of 1,428,424 stock options to the CEO aligns management incentives with long-term shareholder value and company performance.

Future Outlook

The vesting schedule for the newly granted options, with portions vesting on October 1, 2025, and January 1, 2026, indicates a future incentive structure designed to align the CEO's long-term interests with the company's performance.

Industry Context

This filing reflects standard executive compensation practices within publicly traded companies, where equity grants are commonly used to align management interests with long-term shareholder value and incentivize performance.

Corporate Governance

Related Party Transactions

• Grant of 1,428,424 stock options to Branislav Vajdic, the Chief Executive Officer, as part of his executive compensation package.

Stakeholder Impact

• Shareholders: The option grant aligns the CEO's financial interests with shareholder value creation, potentially leading to improved long-term performance. However, it also represents potential future dilution upon exercise.
• Management: The CEO's equity stake is increased, providing a strong incentive for long-term company growth and performance.

Next Steps

• First half of the granted options are scheduled to vest on October 1, 2025.
• The remaining half of the granted options are scheduled to vest on January 1, 2026.

Key Dates

Recommendation

This Form 4 reports a routine executive equity grant, which is a positive for aligning the CEO's interests with shareholders. However, it does not provide sufficient financial or operational data to warrant a change in investment recommendation beyond a neutral 'hold' based solely on this insider transaction report. Investors should consider broader company performance and market conditions.

Keywords

HeartBeam, BEAT, Form 4, insider transaction, stock options, CEO, equity grant, beneficial ownership, Branislav Vajdic